Kiran Dole

905 total citations
22 papers, 532 citations indexed

About

Kiran Dole is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Kiran Dole has authored 22 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Organic Chemistry and 4 papers in Oncology. Recurrent topics in Kiran Dole's work include Glycosylation and Glycoproteins Research (4 papers), Carbohydrate Chemistry and Synthesis (4 papers) and Renal Transplantation Outcomes and Treatments (3 papers). Kiran Dole is often cited by papers focused on Glycosylation and Glycoproteins Research (4 papers), Carbohydrate Chemistry and Synthesis (4 papers) and Renal Transplantation Outcomes and Treatments (3 papers). Kiran Dole collaborates with scholars based in United States, Canada and Switzerland. Kiran Dole's co-authors include Inka Brockhausen, Fabienne Vavasseur, Anthony P. Corfield, Khushi L. Matta, Christos Paraskeva, Neil Myerscough, Hans Paulsen, Monica Ligueros‐Saylan, Yibin Wang and Gangadhar Sunkara and has published in prestigious journals such as Nature Medicine, Journal of Molecular Biology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Kiran Dole

21 papers receiving 518 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kiran Dole United States 13 247 130 106 88 79 22 532
Biehuoy Shieh United States 17 266 1.1× 109 0.8× 86 0.8× 34 0.4× 47 0.6× 33 655
Kensuke Matsumoto Japan 16 310 1.3× 153 1.2× 89 0.8× 78 0.9× 52 0.7× 41 722
Lidia Gackowska Poland 17 319 1.3× 137 1.1× 56 0.5× 45 0.5× 34 0.4× 50 728
Weihua Shen China 15 292 1.2× 82 0.6× 49 0.5× 73 0.8× 22 0.3× 33 682
Yu‐Hou Chen Taiwan 10 232 0.9× 118 0.9× 158 1.5× 44 0.5× 41 0.5× 17 451
Robert C. Murphy United States 12 226 0.9× 161 1.2× 50 0.5× 26 0.3× 47 0.6× 13 768
Pasi Koskimies Finland 17 219 0.9× 60 0.5× 44 0.4× 207 2.4× 66 0.8× 27 867
J Agneray France 16 391 1.6× 231 1.8× 137 1.3× 38 0.4× 38 0.5× 75 778
Riyasat Ali India 13 139 0.6× 90 0.7× 104 1.0× 49 0.6× 40 0.5× 26 500
David Eiznhamer United States 11 297 1.2× 106 0.8× 50 0.5× 19 0.2× 34 0.4× 29 673

Countries citing papers authored by Kiran Dole

Since Specialization
Citations

This map shows the geographic impact of Kiran Dole's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kiran Dole with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kiran Dole more than expected).

Fields of papers citing papers by Kiran Dole

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kiran Dole. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kiran Dole. The network helps show where Kiran Dole may publish in the future.

Co-authorship network of co-authors of Kiran Dole

This figure shows the co-authorship network connecting the top 25 collaborators of Kiran Dole. A scholar is included among the top collaborators of Kiran Dole based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kiran Dole. Kiran Dole is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klickstein, Lloyd B., Laura A. Coleman, Kiran Dole, et al.. (2026). Bimagrumab plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 trial. Nature Medicine. 32(3). 869–882.
2.
3.
Dole, Kiran, Adam L. Feire, Baldur Magnusson, et al.. (2016). A First-in-Human Study To Assess the Safety and Pharmacokinetics of Monoclonal Antibodies against Human Cytomegalovirus in Healthy Volunteers. Antimicrobial Agents and Chemotherapy. 60(5). 2881–2887. 22 indexed citations
4.
Flarakos, Jimmy, Helen Gu, Lai Wang, et al.. (2016). Clinical disposition, metabolism andin vitrodrug–drug interaction properties of omadacycline. Xenobiotica. 47(8). 682–696. 43 indexed citations
5.
Lipsitz, Lewis A., Achille Tchalla, Ikechukwu Iloputaife, et al.. (2016). Evaluation of an Automated Falls Detection Device in Nursing Home Residents. Journal of the American Geriatrics Society. 64(2). 365–368. 23 indexed citations
6.
Gane, Edward, Catherine Stedman, Kiran Dole, et al.. (2016). A Diacylglycerol Transferase 1 Inhibitor Is a Potent Hepatitis C Antiviral in Vitro but Not in Patients in a Randomized Clinical Trial. ACS Infectious Diseases. 3(2). 144–151. 9 indexed citations
7.
Barve, Avantika, Steven J. Kovacs, Annick Ménétrey, et al.. (2014). The effects of CYP3A4 induction and inhibition on the pharmacokinetics of alisporivir in humans. Clinical Pharmacology in Drug Development. 4(1). 25–32. 5 indexed citations
8.
Tornatore, Kathleen M., Kiran Dole, Robin DiFrancesco, et al.. (2011). Mycophenolic Acid Pharmacokinetics During Maintenance Immunosuppression in African American and Caucasian Renal Transplant Recipients. The Journal of Clinical Pharmacology. 51(8). 1213–1222. 22 indexed citations
9.
Lawitz, Eric, R. Gary Rozier, Thomas Marbury, et al.. (2009). 622 SAFETY, AND TOLERABILITY OF NIM811, A NOVEL CYCLOPHILIN INHIBITOR FOR HCV, FOLLOWING SINGLE AND MULTIPLE ASCENDING DOSES IN HEALTHY VOLUNTEERS AND HCV-INFECTED PATIENTS. Journal of Hepatology. 50. S229–S229. 5 indexed citations
10.
Kovarik, John M., Kiran Dole, Gilles‐Jacques Rivière, et al.. (2009). Ketoconazole Increases Fingolimod Blood Levels in a Drug Interaction via CYP4F2 Inhibition. The Journal of Clinical Pharmacology. 49(2). 212–218. 22 indexed citations
11.
He, Yanling, Monica Ligueros‐Saylan, Gangadhar Sunkara, et al.. (2007). Vildagliptin, a Novel Dipeptidyl Peptidase IV Inhibitor, Has No Pharmacokinetic Interactions With the Antihypertensive Agents Amlodipine, Valsartan, and Ramipril in Healthy Subjects. The Journal of Clinical Pharmacology. 48(1). 85–95. 38 indexed citations
12.
Ayalasomayajula, Surya, Kiran Dole, Yanling He, et al.. (2007). Evaluation of the potential for steady-state pharmacokinetic interaction between vildagliptin and simvastatin in healthy subjects. Current Medical Research and Opinion. 23(12). 2913–2920. 37 indexed citations
13.
Liu, Yingxian, Kiran Dole, James R. L. Stanley, et al.. (2002). Engraftment and tumorigenesis of HTLV-1 transformed T cell lines in SCID/bg and NOD/SCID mice. Leukemia Research. 26(6). 561–567. 28 indexed citations
14.
Nguyen, Linh T., Murali Ramanathan, Bianca Weinstock‐Guttman, et al.. (2000). Detection of Cytochrome P450 and Other Drug-Metabolizing Enzyme mRNAs in Peripheral Blood Mononuclear Cells Using DNA Arrays. Drug Metabolism and Disposition. 28(8). 987–993. 23 indexed citations
15.
Turner, Mary Ann, et al.. (1997). Crystallization and preliminary X-ray analysis of human placentalS-adenosylhomocysteine hydrolase. Acta Crystallographica Section D Biological Crystallography. 53(3). 339–341. 7 indexed citations
16.
Dole, Kiran, Francesco Lipari, Annetté Herscovics, & P. Lynne Howell. (1997). Crystallization and Preliminary X-Ray Analysis of the Class 1 α1,2-Mannosidase fromSaccharomyces cerevisiae. Journal of Structural Biology. 120(1). 69–72. 10 indexed citations
17.
18.
Vavasseur, Fabienne, Kiran Dole, Khushi L. Matta, et al.. (1994). O‐glycan biosynthesis in human colorectal adenoma cells during progression to cancer. European Journal of Biochemistry. 222(2). 415–424. 109 indexed citations
19.
Turner, Mary Ann, et al.. (1994). Crystallization and Preliminary X-ray Analysis of a Mutant Duck δ II Crystallin. Journal of Molecular Biology. 243(5). 944–946. 5 indexed citations
20.
Vavasseur, Fabienne, Kiran Dole, Anthony P. Corfield, Christos Paraskeva, & Inka Brockhausen. (1993). S20.5 Changes in the biosynthesis of mucin oligosaccharides in human cancer cells. Glycoconjugate Journal. 10(4). 343–343. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Biehuoy Shieh Breakdown of academic impact, for papers by Kensuke Matsumoto Breakdown of academic impact, for papers by Lidia Gackowska Breakdown of academic impact, for papers by Weihua Shen Breakdown of academic impact, for papers by Yu‐Hou Chen Breakdown of academic impact, for papers by Robert C. Murphy Breakdown of academic impact, for papers by Pasi Koskimies Breakdown of academic impact, for papers by J Agneray Breakdown of academic impact, for papers by Riyasat Ali Breakdown of academic impact, for papers by David Eiznhamer
Rankless by CCL
2026